According to KOBAYASHI Pharmaceutical's latest financial reports the company's current revenue (TTM) is $1.21 B. In 2022 the company made a revenue of $1.24 B a decrease over the years 2021 revenue that were of $1.38 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $1.21 B | -2.17% |
2022 | $1.24 B | -9.99% |
2021 | $1.38 B | -2.75% |
2020 | $1.42 B | -6.67% |
2019 | $1.52 B | 0.52% |
2018 | $1.51 B | 8.66% |
2017 | $1.39 B | |
2015 | $1.12 B | -5.02% |
2014 | $1.18 B | -3.8% |
2013 | $1.23 B | -18.3% |
2012 | $1.50 B | -9% |
2011 | $1.65 B | 10.32% |
2010 | $1.50 B | 9.35% |
2009 | $1.37 B |